Evidence map›Paper›PMID 41419312›Full record

ArticleTobacco control2025

Impact of the California state flavoured tobacco sales restriction on e-cigarette use behaviours among youth.

Jessica L Barrington-Trimis, Louisiana Montserrat Sanchez, Adam M Leventhal, Chanita Hughes Halbert, Lourdes Baezconde-Garbanati, Lisa Henriksen, Megan E Roberts, Alyssa F Harlow

Abstract read
In one paragraph

Article in Tobacco control, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jessica L Barrington-TrimisDepartment of Population and Public Health Sciences, University of Southern California, Los Angeles, California, USA jtrimis@usc.edu.ORCID http://orcid.org/0000-0002-3331-0326
Louisiana Montserrat SanchezDepartment of Population and Public Health Sciences, University of Southern California, Los Angeles, California, USA.ORCID http://orcid.org/0000-0003-1270-6951
Adam M LeventhalDepartment of Population and Public Health Sciences, University of Southern California, Los Angeles, California, USA.ORCID http://orcid.org/0000-0002-1217-525X
Chanita Hughes HalbertDepartment of Population and Public Health Sciences, University of Southern California, Los Angeles, California, USA.
Lourdes Baezconde-GarbanatiDepartment of Population and Public Health Sciences, University of Southern California, Los Angeles, California, USA.
Lisa HenriksenStanford University School of Medicine, Stanford, California, USA.
Megan E RobertsThe Ohio State University, Columbus, Ohio, USA.ORCID http://orcid.org/0000-0003-4743-2145
Alyssa F HarlowDepartment of Population and Public Health Sciences, University of Southern California, Los Angeles, California, USA.ORCID http://orcid.org/0000-0001-6744-6988

Funding

USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORTP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Fumito Ito · 1985 to 2026
$181.4M
Vaping Nicotine and Cannabis Across Adolescence and Young AdulthoodR01CA229617 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BARRINGTON-TRIMIS, JESSICA LOUISE, LEVENTHAL, ADAM MATTHEW · 2019 to 2024
$4.3M
Tobacco Use Treatment Research for Vulnerable PopulationsK24DA048160 · NIDA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Adam Matthew Leventhal · 2019 to 2026
$1.4M
Understanding Transitions from Vaping to Smoking Across AdolescenceK01DA042950 · NIDA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BARRINGTON-TRIMIS, JESSICA LOUISE · 2017 to 2021
$1.0M
The Tobacco and Cannabis Retail Environment, Neighborhood Disadvantage, and Adolescent VapingK01DA058084 · NIDA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Alyssa Fitzpatrick Harlow · 2023 to 2026
$752k
NCI NIH HHS P30 CA014089NCI NIH HHS R01 CA229617NIDA NIH HHS K01 DA042950NIDA NIH HHS K01 DA058084NIDA NIH HHS K24 DA048160
6 · The paper itself

Abstract

backgroundIn December 2022, California prohibited the sale of most flavoured tobacco products; however, limited data are available assessing the impact on adolescent tobacco use behaviours.

methodsWe compared data from youth in 11th grade prior to (fall 2022; n=1212; 'prelaw') and after implementation of the law (fall 2023; n=1026; 'postlaw') at four schools in Southern California (panel study). We assessed past 30-day e-cigarette use, e-cigarette flavours used, perceived difficulty in getting preferred flavours and (among new initiators), flavour at first use, and support for, anticipated impact, and perceived actual impact of the law. We also assessed change in e-cigarette use behaviours prelaw, prelaw to postlaw and postlaw in the same individuals (cohort study).

resultsThere was little change in past 30-day e-cigarette use prelaw (5.8%) vs postlaw (4.1%) (p=0.11). At both time points, all new initiators (100%) reported starting vaping with a flavoured product, most reported past 30-day flavoured e-cigarette use (89.8% vs 90.9%), and most also reported that access to flavours was very or somewhat easy (85.5% vs 83.9%). Youth observed limited impact on e-cigarette use among peers. In the cohort study, few (6.3%) switched completely from e-cigarettes to another nicotine product; many (46.5%) reported no past 30-day nicotine use postlaw (demonstrating a similar pattern as prelaw).

conclusionsWe observed limited change in the use of flavoured e-cigarettes after a state-wide law restricting flavoured tobacco sales was enacted. Findings may reflect inadequate implementation (eg, insufficient enforcement efforts), which warrants further study to reduce youth access to flavoured tobacco products.

Indexed as

Non-cigarette tobacco productsPublic policySurveillance and monitoring

Identifiers

PMID41419312
PMCPMC12904308

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.